""For more than 25 years, the Chesapeake Oncology Hematology Associate is offering the best oncology care to the residents of Maryland. We provide high-quality care for Cancer patients at our medical center, Tate Cancer Center, in Glen Burnie, Maryland. This medical center has infusion facility, state-of-the-art on-site laboratory, highly skilled physicians, nurses, and medical staff to deliver the most compassionate care possible. We offer immunotherapy, infusions, and chemotherapy, to treat various types of cancers, including breast cancer. COHA is a QOPI certified practice. We also accept health insurance from top providers such as Aetna, CIGNA, CareFirst, Medicare, Medicaid and many more to assist you in cancer treatment."

During the past decade, Chesapeake Oncology Hematology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chesapeake Oncology Hematology Associates" #1 collaborator was "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator, "Mena, Raul, M.D." with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "Pharmatech Oncology" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Chesapeake Oncology Hematology Associates" are "Lung Cancer" (2 trials), "Carcinoma, Non-Small Cell Lung" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Neoplasms, Lung" (1 trials). Many other conditions were trialed in "Chesapeake Oncology Hematology Associates" in a lesser frequency.

Most popular intervention types in "Chesapeake Oncology Hematology Associates" are "Drug" (5 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "Docetaxel" (1 trials), "Nipent, Cytoxan, Rituxan" (1 trials), "bexarotene with carboplatin and paclitaxel" (1 trials) and "carboplatin and paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chesapeake Oncology Hematology Associates" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Chesapeake Oncology Hematology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Chesapeake Oncology Hematology Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Chesapeake Oncology Hematology Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".